why choose us

First received: December 12, 2024

Clinical Trial: The xDAPT External Validation Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Coronary Artery Disease

Study Type: OBSERVATIONAL


Official Title: External Validation of an Individualized Patient Centered Machine Learning Model for the Prediction of Ischemic and Bleeding Risk in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary I

Brief Summary: Dual antiplatelet therapy (DAPT) is routinely recommended after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation to prevent thrombotic complications.However, DAPT is also associated with an increased risk of bleeding, which may have a similar or even greater impact on prognosis compared to recurrent ischemic events.To balance these risks, individualized risk stratification at the time of PCI is crucial for determining the optimal DAPT composition and duration, aiming to reduce…

Read more